Clinical Trials in California

Showing 6881-6900 of 8,631 trials

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

NCT01144351

The purpose of this study is to determine the safety and tolerability of ELND002 in patients with relapsing forms of secondary progressive multiple sclerosis (SPMS) or relapsing-remitting multiple sclerosis (RRMS).

Multiple Sclerosis

Elan Pharmaceuticals32 participantsStarted Mar 2010

Berkeley, California, United States • Fresno, California, United States • Newport Beach, California, United States +17 more locations

COMPLETEDPhase 263 miles

Tofacitinib Ointment For Chronic Plaque Psoriasis

NCT01831466

The study is beng done to test if tofacitinib ointment is safe and effective for people with plaque psoriasis. Two dose strengths of tofacitinib ointment (20 mg/g and 10 mg/g) applied once or twice daily are being tested. The safety and effectiveness of tofacitinib ointment used for 12 weeks will be compared to the safety and effectiveness of placebo ointment (vehicle) used for 12 weeks.

Psoriasis VulgarisPsoriasis

Pfizer476 participantsStarted May 2013

Hot Springs, Arkansas, United States • Bakersfield, California, United States • Irvine, California, United States +51 more locations

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Tofacitinib Ointment For Chronic Plaque Psoriasis

Find Trials by Condition in California

First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy

Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer

A Study to Evaluate the Efficacy and Safety of Alglucosidase Alfa Produced at the 4000 L Scale for Pompe Disease

Phase 2b Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Parallel-Group Study to Assess the PD Response and Safety of Three Dose Levels of (PB1023) Injection Following 20 Weeks of Weekly SC Dosing in Adults With T2DM

Multi-center Evaluation of the VERSANT® CT/GC DNA 1.0 Assay (kPCR)in Detecting C. Trachomatis and N. Gonorrhoeae

Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor (PI) and Two Nucleoside Reverse Transcriptase Inhibitors (NRTIs) to a Fixed-dose Tablet Containing Emtricitabine/Rilpivirine/Tenofovir DF

The Ability Of The PD2i Cardiac Analyzer To Predict Risk Of Ventricular Tachyarrhythmic Events

Prehospital Resuscitation On Helicopter Study

Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma

Efficacy and Safety of Ultratrace™ Iobenguane I 131 in Neuroblastoma

Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384)

A Study of Tanespimycin (KOS-953) in Patients With Relapsed-refractory Multiple Myeloma

Neurosurgery Patient Outcomes in Treating Spinal Disorders

Randomized Controlled Trial of Tailored Interactive Multimedia to Reduce Colorectal Cancer Screening Disparities

Safety and Efficacy Study of AR08 for the Treatment of Vasomotor Symptoms (VMS)

Repair of Infected or Contaminated Hernias

Chronic Obstructive Pulmonary Disease (COPD) Activity: Serotonin Transporter (SERT), Cytokines and Depression (CASCADE Study)

A Study of BMS-582949 in Patients With Moderate to Severe Plaque Psoriasis